Schonfeld Strategic Advisors LLC Cure Vac N.V. Call Options Transaction History

Schonfeld Strategic Advisors LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $3.16 Million - $4.51 Million	-93,600 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$49.26 - $74.5 $3.21 Million - $4.85 Million	65,100 Added 228.42%	93,600 $5.11 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $1.62 Million - $3.63 Million	28,500 New	28,500 $2.09 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.